Monte Rosa Therapeutics Inc.
GLUE | NASDAQ
$12.26
+$0.13 (+1.07%)
At close: Sep 21, 2026, 4:00 PM ET
$12.34
+$0.08 (+0.65%)
Pre-market:
Sep 22, 2026, 5:22 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 28.73M | 42.95M | 123.67M | 181.54M | 177.99M | 159.49M | 75.62M | 14.98M | 5.76M | 1.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.03M | 2.03M | n/a | n/a | n/a | 2.06M | 3.96M | 3.96M | 3.96M | 1.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 26.7M | 40.92M | 123.67M | 181.54M | 177.99M | 157.43M | 71.67M | 11.02M | 1.8M | -833K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -181.85M | -148.28M | -54.21M | 8.51M | 14.96M | -2.13M | -81.11M | -128.98M | -139.42M | -144M | -143.31M | -140.94M | -132.33M | -122.34M | -112.38M | -103.28M | -94.79M | -85.68M | -72.88M | -61.43M | -47.95M | -35.22M |
Interest Income | 17.94M | 15.09M | 12.94M | 11.85M | 11.99M | 11.56M | 10.57M | 10.34M | 9.67M | 9.34M | 9.33M | 8.96M | 7.73M | 6.05M | 3.76M | 1.79M | 803K | 189K | 46K | 42K | 31K | 18K |
Pretax Income | -163.97M | -131.88M | -39.72M | 21.95M | 28.42M | 9.46M | -70.13M | -119.01M | -129.93M | -134.86M | -135.01M | -132.52M | -125.13M | -116.61M | -108.5M | -101.16M | -93.68M | -85.61M | -73.96M | -70.17M | -56.9M | -43.85M |
Net Income | -161.12M | -130.01M | -38.63M | 20.95M | 24.17M | 6.15M | -72.7M | -119.39M | -130.41M | -135.28M | -135.35M | -132.88M | -125.32M | -116.61M | -108.5M | -101.16M | -93.68M | -85.61M | -73.96M | -70.17M | -56.9M | -43.85M |
Selling & General & Admin | 39.89M | 37.85M | 36.38M | 34.64M | 33.7M | 34.89M | 35.17M | 34.12M | 34.66M | 33.52M | 32.04M | 31.93M | 30.29M | 28.44M | 27.32M | 24.96M | 22.69M | 19.88M | 15.73M | 12.54M | 8.7M | 5.76M |
Research & Development | 170.69M | 153.38M | 141.5M | 138.39M | 129.33M | 124.67M | 117.61M | 105.88M | 106.57M | 109.65M | 111.27M | 109.01M | 102.04M | 93.9M | 85.06M | 78.32M | 72.1M | 65.8M | 57.16M | 48.89M | 39.25M | 29.46M |
Other Expenses | -2.03M | -2.03M | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 208.55M | 189.2M | 177.88M | 173.03M | 163.03M | 159.56M | 152.78M | 140M | 141.22M | 143.17M | 143.31M | 140.94M | 132.33M | 122.34M | 112.38M | 103.28M | 94.79M | 85.68M | 72.88M | 61.43M | 47.95M | 35.22M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 210.58M | 191.23M | 177.88M | 173.03M | 163.03M | 161.62M | 156.73M | 143.95M | 145.18M | 145.06M | 143.31M | 140.94M | 132.33M | 122.34M | 112.38M | 103.28M | 94.79M | 85.68M | 72.88M | 61.43M | 47.95M | 35.22M |
Income Tax Expense | -2.86M | -1.87M | -1.1M | 1.01M | 4.26M | 3.31M | 2.57M | 384K | 483K | 421K | 338K | 360K | 190K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 101.48M | 65.54M | 65.54M | 82.4M | 82.19M | 82.15M | 61.44M | 82.01M | 71.23M | 60.16M | 56.93M | 49.81M | 49.43M | 49.35M | 48.89M | 46.73M | 46.67M | 46.6M | 45.99M | 45.99M | 45.99M | 42.54M |
Shares Outstanding (Diluted) | 101.48M | 65.54M | 65.54M | 82.4M | 82.19M | 82.96M | 61.44M | 82.01M | 71.23M | 60.16M | 56.93M | 49.81M | 49.43M | 49.35M | 48.89M | 46.73M | 46.67M | 46.6M | 45.99M | 45.99M | 45.99M | 42.54M |
EPS (Basic) | -2.14 | -1.86 | -0.61 | 0.31 | 0.35 | 0.07 | -1.03 | -1.83 | -2.24 | -2.52 | -2.59 | -2.60 | -2.46 | -2.30 | -2.21 | -2.13 | -2 | -5.08 | -4.86 | -5.25 | -5.12 | -1.74 |
EPS (Diluted) | -2.14 | -1.86 | -0.61 | 0.31 | 0.35 | 0.07 | -1.03 | -1.83 | -2.24 | -2.52 | -2.59 | -2.60 | -2.46 | -2.30 | -2.21 | -2.13 | -2 | -5.08 | -4.86 | -5.25 | -5.12 | -1.74 |
EBITDA | -155.85M | -123.54M | -31.37M | 30.28M | 36.76M | 17.73M | -62.01M | -111.1M | -124.55M | -130.15M | -131.05M | -129.33M | -120.48M | -112.46M | -104.76M | -97.68M | -90.65M | -83M | -71.05M | -60.14M | -47.1M | -34.48M |
EBIT | -163.97M | -131.88M | -39.72M | 21.95M | 28.42M | 9.46M | -70.13M | -119.01M | -132.18M | -137.11M | -137.27M | -134.78M | -125.13M | -116.61M | -108.5M | -101.16M | -93.68M | -85.61M | -73.19M | -61.68M | -48.23M | -35.22M |
Depreciation & Amortization | 8.13M | 8.34M | 8.36M | 8.33M | 8.34M | 8.27M | 8.12M | 7.91M | 7.64M | 6.97M | 6.22M | 5.45M | 4.65M | 4.14M | 3.75M | 3.48M | 3.03M | 2.61M | 2.13M | 1.55M | 1.14M | 740K |
Add to Watchlist
Select watchlists to add or remove GLUE